Prosecution Insights
Last updated: May 29, 2026

New England Biolabs Inc.

11 pending office actions • 9 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
9
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
1
Due this week
3
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (1)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
8
Medium (73%)
0
Easy (0%)
3
Unknown (27%)

Rejection Statute Mix

BucketCases
§103 only7 (64%)
§102 only1 (9%)
No statute on record3 (27%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
REGA, KYLE THOMAS 1 62.4% +43.9%
RAMIREZ, DELIA M 1 65.0% +56.5%
GIAMMONA, FRANCESCA FILIPPA 1 35.7% +53.3%
HUTSON, RICHARD G 1 65.1% +52.9%
BUCHANAN, BAILEY CHEYENNE 1 50.0% +46.7%
HANDY, DWAYNE K 1 62.7% +25.3%
CASH, KAILEY ELIZABETH 1 28.6% +48.9%
LIPPOLIS, ALEXANDRA ROSE 1 36.4% +70.1%
ZHANG, KAIJIANG 1 76.5% +35.3%
RAYMONDA, MATTHEW HAROLD 1 38.5% +52.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17907482 Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA CASH, KAILEY ELIZABETH 127d overdue

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17907482 Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA CASH, KAILEY ELIZABETH 127d overdue
18356052 Polynucleotide Error Recognition Methods and Compositions HUTSON, RICHARD G 81d overdue
18621960 DNase I Variants, Compositions, Methods, and Kits RAMIREZ, DELIA M 80d overdue
18969910 Programmable Cleavage of RNA REGA, KYLE THOMAS 30d overdue
18155975 Isolation of High Molecular Weight DNA Using Beads HANDY, DWAYNE K 6d
18323143 Double-Stranded DNA Deaminases and Uses Thereof BUCHANAN, BAILEY CHEYENNE 12d
17825346 Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides ZHANG, KAIJIANG 13d
17820372 Rolling Circle Reverse Transcription of Circular RNA LIPPOLIS, ALEXANDRA ROSE 22d

Top Art Units

Art UnitApps
1652 2
1684 2
1636 1
1671 1
1682 1
1798 1
1683 1
1637 1
1657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18969910 Programmable Cleavage of RNA REGA, KYLE THOMAS 1636 §103 Non-Final OA 30d overdue Pending Dec 05, 2024
18621960 DNase I Variants, Compositions, Methods, and Kits RAMIREZ, DELIA M 1652 Other Non-Final OA 80d overdue Pending Mar 29, 2024
18452104 Rapid Diagnostic Test for LAMP GIAMMONA, FRANCESCA FILIPPA 1671 §103 Non-Final OA 71d Pending Aug 18, 2023
18356052 Polynucleotide Error Recognition Methods and Compositions HUTSON, RICHARD G 1652 §103 Non-Final OA 81d overdue Pending Jul 20, 2023
18323143 Double-Stranded DNA Deaminases and Uses Thereof BUCHANAN, BAILEY CHEYENNE 1682 Other Non-Final OA 12d Pending May 24, 2023
18155975 Isolation of High Molecular Weight DNA Using Beads HANDY, DWAYNE K 1798 §103 Non-Final OA 6d Pending Jan 18, 2023
17907482 Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA CASH, KAILEY ELIZABETH 1683 Other Non-Final OA 127d overdue Pending Sep 27, 2022
17820372 Rolling Circle Reverse Transcription of Circular RNA LIPPOLIS, ALEXANDRA ROSE 1637 §103 Non-Final OA 22d Pending Aug 17, 2022
17825346 Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides ZHANG, KAIJIANG 1684 §102 Non-Final OA 13d Pending May 26, 2022
17637430 Cleavage of Single Stranded DNA Having a Modified Nucleotide RAYMONDA, MATTHEW HAROLD 1684 §103 Non-Final OA 54d Pending Feb 22, 2022
17610081 Chemical Capping for Template Switching YAMASAKI, ROBERT J 1657 §103 Final Rejection 70d Pending Nov 09, 2021

Managing New England Biolabs Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month